Amedisys, Inc. (NASDAQ:AMED – Get Free Report) shares gapped up before the market opened on Friday . The stock had previously closed at $85.95, but opened at $89.50. Amedisys shares last traded at $89.46, with a volume of 536,164 shares changing hands.
Amedisys Stock Up 4.7 %
The business has a fifty day moving average price of $90.45 and a two-hundred day moving average price of $94.43. The firm has a market capitalization of $2.95 billion, a price-to-earnings ratio of 35.70, a price-to-earnings-growth ratio of 1.84 and a beta of 0.73. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19.
Amedisys (NASDAQ:AMED – Get Free Report) last released its quarterly earnings results on Wednesday, November 6th. The health services provider reported $1.00 earnings per share for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19). The business had revenue of $587.67 million during the quarter, compared to analyst estimates of $586.75 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The business’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period in the previous year, the company posted $0.98 EPS. On average, equities analysts expect that Amedisys, Inc. will post 4.45 earnings per share for the current year.
Institutional Trading of Amedisys
About Amedisys
Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.
Read More
- Five stocks we like better than Amedisys
- Where to Find Earnings Call Transcripts
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Top 3 ETFs to Hedge Against Inflation in 2025
- Best Stocks Under $5.00
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.